Details for 2019735973
Up to date per 01.04.2026
Actions
Details for 2019735973
Deleted
European Patent
11.11.2020 A
23.11.2022 B1
05.01.2018
US
201862613939 P
15.03.2018
US
201862643657 P
A61K 31/48 20060101AFI20210927BHEP
Owner
Impel Pharmaceuticals Inc.201 Elliott Avenue West, Suite 260 Seattle, WA 98119US
Representative
No representatives present
Inventor
HOEKMAN, John, D.Impel Neuropharma, Inc. 201 Elliott Ave, Suite 260 Seattle, WA 98119US
SATTERLY, Kelsey, H.Impel Neuropharma, Inc 201 Elliott Ave, Suite 260 Seattle, WA 98119US
SHREWSBURY, Stephen, B.Impel Neuropharma, Inc 201 Elliott Ave, Suite 260 Seattle, WA 98119US
YOUMANS, Scott, B.Impel Neuropharma, Inc 201 Elliott Ave, Suite 260 Seattle, WA 98119US
FULLER, ChristopherImpel Neuropharma, Inc 201 Elliott Ave, Suite 260 Seattle, WA 98119US